-

Global Contact Center Quality Assurance Software Market Forecast to 2029 - Featuring Talkdesk, Arcaris, CloudTalk and CallSource Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Contact Center Quality Assurance Software Market, Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

This report focuses on Contact Center Quality Assurance Software market revenue at the global, regional, and company level.

From a global perspective, this report represents overall Contact Center Quality Assurance Software market size by analyzing historical data and future prospect.

Regionally, this report focuses on several key regions: North America, Europe, Asia Pacific, South America, and Middle East and Africa.

Key Points Covered in the Report

  • Market Revenue of Contact Center Quality Assurance Software Market from 2017 to 2029.
  • Market Forecast for Contact Center Quality Assurance Software Market from 2021 to 2029.
  • Regional Market Share and revenue from 2017 to 2029.
  • Country Market share within region from 2017 to 2029.
  • Key Type and Application revenue and forecast.
  • Company Market Share Analysis, competitive scenario, ranking, and detailed company profiles.
  • Marker driver, restraints, and detailed COVID-19 impact on Contact Center Quality Assurance Software Market.

Key Players of Contact Center Quality Assurance Software Market

  • Talkdesk
  • Arcaris
  • CloudTalk
  • CallSource
  • Scorebuddy
  • Adtrib Aspect Software
  • Enghouse Interactive
  • EvaluAgent
  • Qualitista
  • Genesys
  • Salesforce

Global Contact Center Quality Assurance Software Market

  • 2021-2029
  • Ranorex Others

Key Type of Contact Center Quality Assurance Software Market

  • On-premise
  • Cloud-based

Key Application of Contact Center Quality Assurance Software Market

  • Large Enterprises
  • SMEs

For more information about this report visit https://www.researchandmarkets.com/r/e6wdjc

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Oncology Imaging AI Strategy Report 2025-2032: Pathways, Platforms & Playbooks - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Oncology Imaging AI Strategy Pulse 2025-2032: Pathways, Platforms & Playbooks" report has been added to ResearchAndMarkets.com's offering. The global oncology segment of medical imaging AI grows from US$ 604.7 million in 2023 to US$ 7.74 billion in 2032, a 32.7% CAGR, making it one of the fastest-expanding pools in imaging AI. Oncology Imaging AI Strategy Pulse 2025-2032: Pathways, Platforms & Playbooks is a global deep-dive on how cancer imaging AI is actu...

World Oncology Imaging AI Market Report 2023-2032: Breast and Lung Screening Programs, Complex CT/MRI Staging, PET-based Theranostics, and RT Planning - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "World Market for Oncology Imaging AI, 2023-2032" report has been added to ResearchAndMarkets.com's offering. Oncology is where medical imaging AI is being tested most aggressively - and where it is starting to stick. Breast and lung screening programs, complex CT/MRI staging, PET-based theranostics, and RT planning are all pushing clinicians toward faster, more consistent, more quantitative imaging decisions. This report quantifies and explains that shift. It analy...

GLP-1 Analogues Market Research 2025: Increasing Diabetes and Obesity Rates and a Strong R&D Pipeline Support Market Expansion - Forecast to 2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "GLP-1 Analogues Market" report has been added to ResearchAndMarkets.com's offering. This report provides detailed information on glucagon-like peptide-1 (GLP-1) analogues. It analyzes market trends for GLP-1 analogues, with data from 2024, estimates from 2025, projections of compound annual growth rates (CAGRs) through 2030 (the forecast period 2025-2030) and regional markets for GLP-1 analogues. This report highlights the current and future market potential of GLP...
Back to Newsroom